New York S 7357: Requires hospital and emergency room physicians to notify a patient's prescriber that such patient is being treated for a controlled substance overdose

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S07357 Summary:

BILL NOS07357 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORLANZA

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §§3371 & 3343-a, Pub Health L

&nbsp

Requires hospital and emergency room physicians to consult the prescription monitoring program registry and to notify a patient's prescriber that such patient is being treated for a controlled substance overdose.

Go to top S07357 Actions:

BILL NOS07357 

&nbsp

04/10/2025REFERRED TO HEALTH

01/07/2026REFERRED TO HEALTH

Go to topS07357 Committee&nbspVotes:

Go to topS07357 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS07357 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 7357

 2025-2026 Regular Sessions

 IN SENATE

 April 10, 2025
 ___________

 Introduced by Sen. LANZA -- read twice and ordered printed, and when
 printed to be committed to the Committee on Health

 AN ACT to amend the public health law, in relation to requiring hospital
 and emergency room physicians to notify a patient's prescriber that
 such patient is being treated for a controlled substance overdose

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Paragraphs (i) and (j) of subdivision 1 of section 3371 of
 2 the public health law, as added by section 4 of part A of chapter 447 of
 3 the laws of 2012, are amended to read as follows:
 4 (i) to a medical examiner or coroner who is an officer of or employed
 5 by a state or local government, pursuant to [his or her] their official
 6 duties; [and]
 7 (j) to an individual for the purpose of providing such individual with
 8 [his or her] their own controlled substance history or, in appropriate
 9 circumstances, in the case of a patient who lacks capacity to make
 10 health care decisions, a person who has legal authority to make such
 11 decisions for the patient and who would have legal access to the
 12 patient's health care records, if requested from the department pursuant
 13 to subdivision six of section thirty-three hundred forty-three-a of this
 14 article or from a treating practitioner pursuant to subparagraph (iv) of
 15 paragraph (a) of subdivision two of this section; and
 16 (k) to a practitioner to inform such practitioner that a patient is
 17 under treatment for a controlled substance overdose by hospital or emer-
 18 gency room practitioner for the purposes of subdivision two of this
 19 section.
 20 § 2. Paragraph (a) of subdivision 2 of section 3371 of the public
 21 health law, as amended by section 56-b of chapter 92 of the laws of
 22 2021, is amended to read as follows:
 23 (a) a practitioner, or a designee authorized by such practitioner
 24 pursuant to paragraph (b) of subdivision two of section thirty-three

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD11100-01-5

 S. 7357 2

 1 hundred forty-three-a, section thirty-three hundred sixty-one of this
 2 article or section thirty of the cannabis law, for the purposes of: (i)
 3 informing the practitioner that a patient may be under treatment with a
 4 controlled substance by another practitioner or that a patient is under
 5 treatment for a controlled substance overdose; (ii) providing the prac-
 6 titioner with notifications of controlled substance activity as deemed
 7 relevant by the department, including but not limited to a notification
 8 made available on a monthly or other periodic basis through the registry
 9 of controlled substances activity pertaining to [his or her] such prac-
 10 titioner's patient; (iii) allowing the practitioner, through consulta-
 11 tion of the prescription monitoring program registry, to review [his or
 12 her] such practitioner's patient's controlled substances history as
 13 required by section thirty-three hundred forty-three-a, section thirty-
 14 three hundred sixty-one of this article or section thirty of the canna-
 15 bis law; and (iv) providing to [his or her] such practitioner's patient,
 16 or person authorized pursuant to paragraph (j) of subdivision one of
 17 this section, upon request, a copy of such patient's controlled
 18 substance history as is available to the practitioner through the
 19 prescription monitoring program r